Acute demyelinating lesions with restricted diffusion in multiple sclerosis

Konstantin E Balashov1, Eric Lindzen

  • 1Department of Neurology, UMDNJ, Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA. kbalashov@yahoo.com

Multiple Sclerosis (Houndmills, Basingstoke, England)
|April 24, 2012
PubMed
Abstract

Insights

Acute demyelinating lesions exhibiting restricted diffusion (ADLRD) in multiple sclerosis (MS) may represent a new variant. These ADLRD present diagnostic challenges, particularly in differentiating from stroke in young adults.

Area of Science:

  • Neurology
  • Radiology
  • Neuroimmunology

Background:

  • Typical acute demyelinating lesions in relapsing-remitting multiple sclerosis (RRMS) show vasogenic edema and increased diffusion on MRI.
  • Acute ischemic lesions typically present with cytotoxic edema and restricted diffusion.
  • Recent reports indicate some acute demyelinating lesions in MS can exhibit restricted diffusion (ADLRD).

Purpose of the Study:

  • To assess the morphology, distribution, signal characteristics, and temporal changes of nine ADLRD.
  • To correlate clinical findings with ADLRD.
  • To review previously published ADLRD case reports.

Main Methods:

  • Retrospective case series conducted at two academic centers.
  • Compared MRI characteristics of nine ADLRD in six RRMS patients.
  • Controlled comparison with typical active, contrast-enhancing lesions in RRMS patients.

Main Results:

  • ADLRD size was comparable to typical MS lesions.
  • Periventricular location and faint T2-weighted signal were more common in ADLRD.
  • Two patients developed new ADLRD on follow-up scans.

Conclusions:

  • ADLRD appear to be a novel variant of MS lesions.
  • Restricted diffusion in ADLRD poses a diagnostic challenge for stroke in young adults.
  • The underlying pathogenesis of ADLRD requires further investigation.